ANNALS OF ONCOLOGY

Rivista

Codice:

E009451

ISSN:

0923-7534

Dati Generali

Pubblicazioni (351)

. The level of HER2/neu amplification may have a correlation with some relevant histopathologcal features of early stage breast cancer

Poster

18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy

Abstract

18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy

Articolo

1995PApplication of ESCAT and OncoKB scales in liquid biopsy (LB) in advanced NSCLC patients (pts): Is it feasible and reliable?

Abstract

2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial

Articolo

27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells

Contributo in Atti di convegno

55P - Incidence and clinical implications of late immune-related adverse events in long responders to PD-1/PD-L1 checkpoint inhibitors: a multicenter study.

Abstract

721P Ipilimumab and nivolumab compassionate use program in metastatic renal cell carcinoma patients with intermediate or poor IMDC risk score: The large multicenter Italian study

Abstract

A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC)

Articolo

A PHASE IB CLINICAL STUDY WITH 18F-FDG-PET RESPONSE EVALUATION OF THE COMBINATION OF TEMSIROLIMUS (T) AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN BREAST, ENDOMETRIAL AND OVARIAN CANCER

Abstract

A Phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small cell lung cancer.

Articolo

A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1]

Articolo

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Articolo

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer

Articolo

A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer

Articolo

A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment

Articolo

A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study

Articolo

A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer

Articolo

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin

Articolo

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study

Articolo

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Articolo

ADDRESSING CLINICAL CHALLENGES IN TARGETED THERAPIES WITH ADVANCED IMAGING

Abstract

ADJUVANT RADIOIMMUNOTHERAPY AFTER RADIOFREQUENCY ABLATION OF COLORECTAL LIVER METASTASES

Abstract

ADJUVANT RADIOIMMUNOTHERAPY IMPROVES SURVIVAL OF RATS AFTER RESECTION OF COLORECTAL LIVER METASTASES

Abstract

APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas

Articolo

ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)

Abstract

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Articolo

Activity and safety of trabectedin in patients with sarcomatoid / biphasic malignant pleural mesothelioma (MPM)

Abstract

Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer

Articolo

Activity of single agent vinorelbine in pretreated non-Hodgkin's lymphoma

Articolo

Addressing the quality of life needs of older patients with cancer: A SIOG consensus paper and practical guide

Articolo

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscleinvasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial

Articolo

Advanced soft tissue sarcoma: How many more trials with anthracyclines and ifosfamide?

Articolo

Allelic expression of p73 in human ovarian cancers

Articolo

Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

Articolo

Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.

Articolo

An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy

Articolo

Application of ESCAT and OncoKB scales in liquid biopsy (LB) in advanced NSCLC patients (pts): Is it feasible and reliable?

Abstract

Assessment of colorectal liver metastases with multiphase CT, FDG-PET, and intra-operative ultrasound

Articolo

Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors

Recensione

BCL2, BCL6, MYC, CCND1, MALT1 AND BCL10 GENE REARRANGEMENTS IN PRIMARY TESTICULAR LYMPHOMASDETECTED BY FLUORESCENT IN SITU HYBRIDIZATION WITH SPLIT SIGNAL PROBES

Abstract

BEVACIZUMAB BEYOND PROGRESSION: HOW TO MONITOR TREATMENT EFFICACY? RESULTS OF A FUNCTIONAL IMAGING STUDY IN MURINE COLORECTAL CANCER

Abstract

Baseline Absolute Neutrophil Count (ANC), derived Neutrophil-to-Lymphocyte Ratio (dNLR) and Platelet-to-Lymphocyte Ratio (PLR) and outcome in Non Small Cell Lung Cancer (NSCLC) treated with Nivolumab or Docetaxel: a preliminary analysis.

Abstract

Bevacizumab in combination with FOLFIRI as first-line treatment for metastatic colorectal cancer: outcomes from a single center experience

Abstract

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Articolo

Biological agents in head and neck cancer

Articolo

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

Articolo

Breast cancer vaccines: a clinical reality or fairy tale?

Articolo

CASE CONTROL STUDY ON TWO DIFFERENT CHEMOTHERAPY REGIMENS IN ADVANCED MIXED MULLERIAN TUMOURS

Articolo

CHEMOTHERAPY IN THE MULTIDISCIPLINARY APPROACH TO SOFT-TISSUE SARCOMAS - EORTC SOFT-TISSUE AND BONE SARCOMA GROUP STUDIES IN PERSPECTIVE

Articolo

COMBINED-MODALITY TREATMENT FOR PRIMARY GASTROINTESTINAL NON-HODGKINS-LYMPHOMA - THE MILAN CANCER INSTITUTE EXPERIENCE

Articolo

Cancer patients and survivors: changing words or changing culture ?

Articolo

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: A proof-of-principle

Articolo

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle (vol 25, pg 1729, 2014)

Articolo

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial

Articolo

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines

Articolo

Characterization of low HER2 expressions in de-novo metastatic breast cancer

Abstract

Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer

Articolo

Chemotherapy-free treatments: Are we ready for prime time?

Articolo

Chronic oral etoposide in small-cell lung cancer: Clinical and pharmacokinetic results

Articolo

Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma

Abstract

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion

Articolo

Clinical and pathological factors predicting long-term disease control with lapatinib and capecitabine for patients with HER2 positive metastastic breast cancer: results from a multicenter retrospective study

Abstract

Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa

Articolo

Clinical implications of immunohistochemical assessment of somatostatin receptor subtypes 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours.

Abstract

Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours

Abstract

Clinical outcomes in patients with metastatic (m plus ) melanoma treated with immune-checkpoint inhibitors (ICI) with or without radiotherapy (RT): A monocentric retrospective study

Articolo

Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer

Articolo

Colorectal cancer liver metastases treated with target therapies: monitoring response with contrast-enhanced ultrasonography (CE-US).

Poster

Colorectal liver metastases: Appraisal of resection versus chemotherapy

Articolo

Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases; A prospective study

Abstract

Comparison of filgrastim and pegfilgrastim prophylaxis in sarcoma patients receiving highly myelosuppressive chemotherapy

Articolo

Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease

Articolo

Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor

Articolo

Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors

Articolo

Consolidation high-dose chemotherapy for patients with primary mediastinal nonseminomatous germ cell tumor

Articolo

Corrections to "Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors"

Articolo

DETECTION OF DISTANT METASTASES WITH FDG-PET AND CT IN 251 CLINICALLY STAGE III MELANOMA PATIENTS

Articolo

DNA-topoisomerase I activity and content in epithelial ovarian cancer

Articolo

DRUGS 10 YEARS LATER - EPIRUBICIN

Articolo

Daunorubicin and daunorubicinol levels in human glioma tumors after administration of liposomal encapsulated daunorubicin (Daunoxome)

Articolo

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines

Articolo

Differences in docetaxel and paclitaxel activity in resistant tumor cells which express MRP: Need of comparative clinical trials in resistant patients

Articolo

Different metastatic pattern according to the EGFR mutational status in a cohort of lung adenocarcinomas (ADCs): a single-institution report.

Abstract

Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding

Articolo

Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study

Articolo

Docetaxel in combination with gemcitabine as second line treatment in patients with platinum resistant advanced NSCLC

Poster

Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer

Articolo

Dose-escalation of CHOP in non-Hodgkin's lymphoma

Articolo

Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.

Articolo

Durable complete response following chemotherapy and trastuzumab for metastatic HER2-positive breast cancer

Articolo

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

Articolo

EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients

Articolo

EPIRUBICIN PLUS IFOSFAMIDE AND DACARBAZINE (EID) IN ADVANCED SOFT-TISSUE SARCOMAS

Articolo

ERYTHROPOIETIN (EPO) BLOOD CONCENTRATION IN PATIENTS WITH SOLID TUMOR-INDUCED BONE MARROW INFILTRATION

Articolo

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours

Articolo

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Articolo

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

Articolo

ESMO–EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease

Articolo

Early response evaluation of antiangiogenic therapy: use of contrast-enhanced ultrasonography (CE-US) in hepatocellular carcinoma

Poster

Early restaging positron emission tomography with 18 F-fluorodeoxyglucose in aggressive non-Hodgkin's lymphomas: is it too easy to be true?

Articolo

Effect of Ecteinascidin-743 (ET-743) on the interaction between transcription factors and DNA

Articolo

Efficacy and safety of biweekly intravenous administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small cell and non-small cell lung cancer: a multi-tumour, multi.institutional Phase II study

Articolo

Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)

Articolo

Efficacy and safety of single agent pan-HER inhibitor Dacomitinib in the treatment of unresectable or metastatic skin squamous cell cancer - Trial in progress

Articolo

Efficacy and tolerability of a single-day three drugs combination of aprepitant, palonosetron and dexamethasone in patients receiving moderately emetogenic chemotherapy

Abstract

Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial

Articolo

Elapsed time for an unresolved adverse event: systemic anticancer therapy-induced neurotoxicity calls for action

Articolo

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Articolo

Epidermal Growth Factor Receptor mutational status predicts patterns of metastatic spread in treatment-naïve Adenocarcinomas of the lung.

Abstract

Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: a multicentric phase I-II study

Articolo

Estimating 12-weeks death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogram

Articolo

Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group

Articolo

Evaluation of the hematotoxic potential of methoxymorpholinyl-doxorubicin (MMDX) metabolites in patients plasma by clonogenic assays on hemopoietic progenitor cells

Articolo

Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.

Articolo

F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy

Abstract

FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma

Articolo

Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial

Articolo

Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial

Articolo

Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil (TPF) induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced nasopharyngeal cancer (LANPC)

Articolo

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease

Articolo

First-line bevacizumab combined with reduced dose interferon-alpha 2a is active in patients with metastatic renal cell carcinoma

Articolo

First-line chemotherapy in over-70 patients with colon cancer.

Abstract

Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: A phase II randomized study

Articolo

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Articolo

Free mobility of medical oncologists across the European Union: still a false myth

Articolo

Fulvestrant for advanced male breast cancer patients: a case series

Articolo

GEMCITABINE (G) AT FIXED DOSE RATE (FDR) INFUSION, COMBINED WITH CISPLATIN (C), IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC). A PHASE II STUDY WITH INCREMENTAL G DOSES

Articolo

Gemcitabine (GEM) and pegylated liposomal doxorubicin (PLD) in recurrent metastatic breast carcinoma: A phase II study

Articolo

Gene expression analysis in oral potentially malignant disorders (OPMD) with dysplasia identifies patients at high risk of malignant transformation

Articolo

Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways

Abstract

Genetic profiling using plasma-derived cell-free DNA in therapy-naive hepatocellular carcinoma patients: A pilot study

Articolo

Glutathione S-transferase activity in epithelial ovarian cancer: Association with response to chemotherapy and disease outcome

Articolo

HEALTHCARE ASSOCIATED INFECTIONS IN HEAD AND NECK CARCINOMA PATIENTS TREATED WITH CHEMOTHERAPY AND/OR RADIOTHERAPY

Articolo

HER 2 POSITIVE BREAST CANCER WITH CENTRAL NERVOUS METASTASES.PATHOLOGICAL FEATURES AND CLINICAL OUTCOME

Abstract

HER2 positive breast cancer with central nervous system metastases: Pathological features and clinical outcome

Articolo

HER2-positive breast cancer and CNS metastases: Prognostic factors and clinical outcome

Abstract

HMGA1 is a new biomarker of liposarcoma progression

Abstract

Head and neck cancer

Articolo

Health and economic outcomes of two different follow up strategies in effectively cured advanced head and neck cancer patients-Trial in progress

Articolo

High incidence of INR alteration in gastrointestinal cancer patients treated with mini-dose warfarin and 5-fluorouracil-based regimens

Articolo

High incidence of hypocalcemia in patients with bone metastases from different kinds of neoplasms, treated with zoledronate

Abstract

High-dose chemotherapy as adjuvant treatment for high-risk primary breast cancer patients

Articolo

High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors : mature results of an Italian randomized phase II study

Articolo

IMPACT OF SOLUBLE TUMOR NECROSIS FACTOR-RECEPTORS (STNF-RS) SHEDDING ON OUTCOME IN PATIENTS TREATED WITH NGR-HTNF

Abstract

IMPROVED SELECTION OF PATIENTS FOR HEPATIC SURGERY OF COLORECTAL LIVER METASTASES WITH FDG-PET: RESULTS OF THE RANDOMIZED DUTCH POLEM STUDY

Abstract

INDUCTION CHEMOTHERAPY WITHIN A MULTIMODALITYREATMENT OF NASAL CAVITY AND ETHMOID SINUS MALIGNANT EPITHELIAL TUMOURS: REPORT OF AN HOMOGENEOUS SERIES OF PATIENTS

Articolo

Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies

Articolo

Imatinib mesylate in desmoplastic small round cell tumour

Poster

Immunotherapy and epithelial ovarian cancer: a double-edged sword?

Articolo

Impact of maintenance Pemetrexed in the management of non-progressing malignant mesotheliomas after standard fist-line chemotherapy: a single institution experience.

Abstract

Increased activity of indolent liver metastases after resection of a primary colorectal tumor

Articolo

Initial chemotherapy for primary resectable large-cell lymphoma of the stomach

Articolo

Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients

Articolo

Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib

Articolo

Intensified CHOP in non-Hodgkin's lymphoma: What we know and what we need to know

Articolo

Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide

Articolo

Intensified CHOP regimen in aggressive lymphomas: minimal dose intensity and dose density of doxorubicin and cyclophosphamide

Articolo

Intensified PEFG regimen in stage III-IV pancreatic adenocarcinoma: A phase I trial

Abstract

Intensified chemotherapy with stem-cell rescue in germ-cell tumors

Articolo

Irinotecan and raltitrexed: an active combination in advanced colorectal cancer

Articolo

KEYNOTE-B21: a missed opportunity or a turning point in adjuvant immunotherapy for dMMR endometrial cancer?

Articolo

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

Articolo

L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure

Articolo

L-asparagine depletion in plasma and cerebro-spinal fluid of children with acute lymphoblastic leukemia during subsequent exposures to Erwinia L-asparaginase

Articolo

L-asparagine-depletion: Another opinion - Response

Articolo

Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

Abstract

Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST).

Articolo

Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)

Articolo

MALIGNANT ASCITES IN CLINICAL PRACTICE: AIOM FOUNDATION SURVEY

Articolo

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients

Articolo

MGMT IN PRIMARY NODAL DIFFUSE LARGE B-CELLSLYMPHOMAS: SIGNIFICANCE OF IMMUNOHISTOCHEMICALEXPRESSION AND METHYLATION STATUS

Abstract

MICROMETASTASES SITE AND SIZE TO SENTINEL LYMPH NODES PREDICT ADDITIONAL AXILLARY METASTASES IN PATIENTS WITH BREAST CANCER

Articolo

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy

Articolo

MODULATION OF IL-2 CANCER IMMUNOTHERAPY BY CYCLOOXYGENASE (COX)-2 INHIBITORS: THERAPEUTIC AND BIOLOGICAL RESULTS OF IL-2 PLUS CELECOXIB IN METASTATIC RENAL CELL CANCER (RCC) PROGRESSING ON IL-2 ALONE

Abstract

Malignant pleural effusion (MPE) characterized with 11C-Methionine PET/CT before and after talc pleurodesis: interim evaluation of a prospective clinical trial

Articolo

Malignant pleural mesothelioma

Articolo

Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG)

Articolo

Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

Articolo

Medical Oncologists must get more involved in systemic treatment of Hepatocellular Carcinoma

Articolo

Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapy

Articolo

Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen

Articolo

Mode of action of Ecteinascidin 743, a natural marine compound with antitumoral activity

Articolo

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Articolo

Morphology of tumour-associated macrophages dictates the prognosis of patients with colorectal liver metastases

Abstract

Multidisciplinary approach for poor prognosis sinonasal tumors: Phase II studies of chemotherapy, surgery, photon and heavy ion radiotherapy integration for more effective and less toxic treatment-Trials in progress

Articolo

NGR-HTNF IN COMBINATION WITH DOXORUBICIN IN PROGRESSIVE OR RECURRENT OVARIAN CANCER

Articolo

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Articolo

Navigating into a stormy sea: liquid biopsy enters peri-operative management in early-stage non-small cell lung cancer

Articolo

Neutrophil to Lymphocyte Ratio (NLR) as predictive factor in patients with metastatic soft tissue sarcoma (STS) treated with trabectedin (T).

Poster

New tricks for old biomarkers: thymidylate synthase expression as a predictor of pemetrexed activity in malignant mesothelioma

Articolo

Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Articolo

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial

Articolo

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040

Articolo

Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Articolo

Non-randomised comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases; A prospective study

Articolo

Not only tumor but also therapy heterogeneity

Articolo

Nuclear medicine imaging of neuroendocrine tumours

Articolo

ONCOMOVIES: CANCER IN CINEMA

Articolo

OUTCOME OF OROPHARYNGEAL CANCER ACCORDING TO TREATMENT IN DIFFERENT RISK-PROFILE GROUPS: ANALYSIS OF A RETROSPECTIVE SERIES OF PATIENTS TREATED IN A TERTIARY CANCER CENTRE

Articolo

Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy

Articolo

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

Articolo

On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2

Abstract

Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis

Articolo

Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options

Articolo

Optimizing residual surgery for patients with primary extragonadal germ cell tumors

Abstract

Oral vinorelbine in elderly or unfit patients with metastatic NSCLC

Abstract

Outcome of high-grade gliomas (HGGs) treated into immunotherapeutic early-phase clinical trials (ieCTs): A single-center experience

Abstract

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial

Articolo

PARPi related toxicities: do we need more appropriate instruments to evaluate it?

Articolo

PEFG salvage therapy inpatients with gemcitabine-resistant advanced pancreatic cancer (PC)

Abstract

PERFUSION COMPUTED TOMOGRAPHY AS PROGNOSTIC AND PREDICTIVE FACTOR IN PATIENTS WITH COLORECTAL CANCER LIVER METASTASES TREATED WITH BEVACIZUMAB

Contributo in Atti di convegno

PHASE I AND PHARMACODYNAMIC STUDY OF NGR-HTNF ADMINISTERED AT HIGH DOSES IN REFRACTORY PATIENTS WITH SOLID TUMORS

Abstract

PHASE II STUDY OF LIPOSOMAL DOXORUBICIN AND GEMCITABINE IN THE TREATMENT OF RECURRENT OVARIAN CANCER

Articolo

PROGNOSTIC FACTORS INFLUENCING OUTCOME OF PATIENTS WITH RECURRENT OR METASTATIC CARCINOMA (RandM) OF THE HEAD AND NECK: RESULTS OF AN ITALIAN MONOINSTITUTIONAL STUDY

Articolo

PROGNOSTIC VALUE OF RESIDUAL CT SCAN MASS IN AGGRESSIVE LYMPHOMAS PATIENTS WITH PET NEGATIVE AFTER CHEMO +/- RADIOTERAPY

Abstract

PROGNOSTIC VALUE OF RESIDUAL CT SCAN MASS IN AGGRESSIVE LYMPHOMAS PATIENTS WITH PET NEGATIVE AFTER CHEMO +/- RADIOTERAPY

Abstract

Paclitaxel induces significant changes in epidoxorubicin distribution in mice

Articolo

Pain related to cancer treatments and diagnostic procedures: a no man's land?

Articolo

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

Articolo

Palonosetron plus three-day aprepitant and dexamethasone schedule to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy

Abstract

Palonosetron plus three-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy

Poster

Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support

Articolo

Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome)

Articolo

Pembrolizumab for patients with PD-L1-positive advanced carcinoid or pancreatic neuroendocrine tumors: results from the KEYNOTE-028 study

Articolo

Perfusion Computed Tomography as prognostic and predictive factor in patients with colorectal cancer liver metastases treated with bevacizumab

Poster

Pexg (P : Cisplatin, E : Epirubicin, X : Capecitabine, G : Gemcitabine) versus PDXG (D : Docetaxel) regimen in advanced pancreatic cancer: A randomized phase II trial

Abstract

Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin

Articolo

Phase 3 (COSMIC-312) study of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy

Articolo

Phase I clinical and pharmacokinetic (PK) study of oral (PO) methoxy-morpholino doxorubicin (PNU 152243) on a single intermittent schedule

Articolo

Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days

Articolo

Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1 in patients with hepatocellular carcinoma

Articolo

Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors

Articolo

Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy

Articolo

Phase II study of preoperative TPF chemotherapy in molecularly selected resectable oral cavity cancer-Trial in progress

Articolo

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients

Articolo

Phase III trial comparing 3 to 6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

Articolo

Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I

Articolo

Plasma and intracellular pharmacokinetic (PK) study of prolonged infusion (PI) of gemcitabine (G) in combination with bolus cisplatin (C), in advanced nonsmall cell lung cancer.: Preliminary results

Articolo

Positron emission tomography with F18-fluorodeoxyglucose (FDG-PET) in malignant pleural mesothelioma (MPM): Evaluation of response to chemotherapy by quantitative assessment of standardized uptake value (SUV)

Abstract

Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial

Articolo

Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas

Articolo

Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients

Articolo

Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome

Articolo

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

Articolo

Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study

Articolo

Prognostic value of carbohydrate antigen (CA) 19-9 decrease in response to chemotherapy for advanced pancreatic adenocarcinoma (PA)

Abstract

Prognostic value of the immune-related transcriptome in biliary tract cancers

Abstract

Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy

Articolo

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

Articolo

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial

Articolo

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

Articolo

Quality of life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

Articolo

Radiation therapy for locally advanced pancreatic adenocarcinoma: a therapeutic option which should not be forgotten. Letter to the Editor regarding: “Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up” by Huguet et al

Articolo

Radiolabeled bevacizumab as a tracer of VEGF-A expression in patients with colorectal liver metastases

Articolo

Radiotherapy (RT) plus concomitant and adjuvant temozolomide (TMZ) for high-grade gliomas (HGGS) other than gliobastoma multiforme (GBM): Preliminary results

Abstract

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Articolo

Real-life data on the cardiac toxicity of adjuvant fixed-dose subcutaneous trastuzumab in HER2-positive breast cancer

Abstract

Real-life data on the cardiac toxicity of adjuvant fixed-dose subcutaneous trastuzumab in HER2-positive breast cance

Abstract

Reliability of the HER2 status assessment by immunohistochemistry for breast cancer patients after preoperative chemotherapy

Abstract

Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer

Articolo

Results of salvage surgery for metastatic sarcomas.

Articolo

RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN)

Abstract

Retrospective analysis of the role of adjuvant chemotherapy and microRNAs expression in resected cholangiocarcinomas (CCAs)

Abstract

Retrospective analysis of the therapeutic efficacy of platinum/etoposide schedules in the treatment of advanced poor differentiated neuroendocrine carcinomas of the lung.

Abstract

Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients

Articolo

Role of adjuvant chemotherapy in early-stage endometrioid and clear-cell ovarian cancer

Articolo

Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

Articolo

Role of gemcitabine in ovarian cancer treatment

Articolo

Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer

Articolo

Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools

Articolo

Role of stereotactic body radiation therapy in the management of oligometastatic pancreatic cancer single institution experience

Abstract

SAFETY AND EFFICACY OF ORAL COMBINATION CHEMOTHERAPY IN METASTATIC BREAST CANCER: VINORELBINE AND CAPECITABINE

Contributo in Atti di convegno

SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA

Contributo in Atti di convegno

SAKK 17/16 - Lurbinectedin as second or third line palliative chemotherapy in malignant pleural mesothelioma (MPM): A multi-center, single-arm phase II trial

Poster

SAMITAL IN PROPHYLAXIS OF CHEMO-RADIOTHERAPY (CT-RT) INDUCED MUCOSITIS IN HEAD AND NECK SQUAMOCELLULAR CANCER (HNSCC) PATIENTS (PTS): RESULTS OF A PROSPECTIVE MONOINSTITUTIONAL PHASE II TRIAL

Articolo

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal

Articolo

Safety and efficacy of bevacizumab with first-line FOLFIRI for metastatic colorectal cancer: single center experience

Poster

Safety of autologous fat grafting in breast cancer: A multicenter Italian study among 17 Senonetwork Breast Units

Articolo

Safety, Tollerability and Early Response Evaluation of Sorafenib In Hepatocellular Carcinoma In Elderly: Use of Contrast-enhanced Ultrasonography (ce-us)

Contributo in Atti di convegno

Safety, tolerability and early response evaluation of sarafenib in hepatocellular carcinoma in erderly: use of contrast-enhanced ultrasonography (CE-US).

Abstract

Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.

Articolo

Salvage therapy in advanced pancreatic adenocarcinoma

Abstract

Scintigraphic imaging of VEGF-A expression with radiolabeled ANTI-VEGF monoclonal antibody (bevacizumab)

Articolo

Sequential administration of temozolomide and fotemustine: Depletion of O-6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours

Articolo

Sex-based differences of the tumor mutational burden and T-cell inflammation of the tumor microenvironment

Articolo

Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group

Articolo

Short-schedule cisplatin andvinorelbine as induction chemotherapy in stage IIIA(N2)-IIIB non small cell lung cancer (NSCLC)

Abstract

Sinusal localization of nodal micrometastases is a prognostic factor in breast cancer

Articolo

Site of metastatic disease influences adenoid cystic cancer (ACC) patients' outcome

Articolo

Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers

Articolo

Some hope from marine natural products

Articolo

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma : a prospective feasibility analysis

Articolo

Sorafenib is active on lung metastases from synovial sarcoma

Articolo

Src as a potential therapeutic target in non-small-cell lung cancer

Recensione

Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014)

Articolo

Superiority of CHOI vs RECIST criteria in evaluating outcome of advanced soft tissue sarcoma (STS) patients treated with sorafenib

Poster

Suspicious for recurrent low and high grade glioma and indeterminate MRI: the role of 18F-DOPA PET/CT

Articolo

T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results

Articolo

THE 70- GENES EXPRESSION PROFILE FOR BREAST CANCER PATIENTS IN ITALIAN HOSPITALS

Abstract

THE 70-GENE EXPRESSION PROFILE FOR BREAST CANCERPATIENTS IN ITALIAN HOSPITALS

Articolo

THE IMPACT OF INDUCTION CHEMOTHERAPY ON CISPLATION DOSE INTENSITY DURING CHEMO-RADIOTHERAPY (CTRT) IN OROPHARYNGEAL SQUAMOUS CELL CANCER (OPC)

Articolo

THE ROLE OF THYMIDTYLATE SYNTHASE (TS) AND EXCISION REPAIR CROSS-COMPLEMENTING GROUP 1 (ERCC1) IMMUNOHISTOCHEMICAL EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) PATIENTS TREATED WITH PEMETREXED AND CARBOPLATIN

Abstract

TNBC universe: A monocentric retrospective analyses of TILs and AR as prognostic markers

Abstract

TUMOR STAGE, HUMANPAPILLOMA VIRUS (HPV) AND SMOKING STATUS AFFECT THE SURVIVAL OF PATIENTS WITH OROPHARYNGEAL CANCER: AN ITALIAN VALIDATION STUDY

Articolo

Targeted therapy in nuclear medicine-current status and future prospects

Articolo

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Articolo

The evolving impact of genomic biomarker landscape in stage II colorectal cancer (CRC)

Abstract

The impact of FDG-PET in the management of colorectal liver metastases: A systematic review and meta-analysis

Articolo

The impact of mass spectrometry multigenic platform on the management of metastatic colorectal patients

Abstract

The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study

Articolo

The metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cells

Articolo

The role of FDG-PET in the selection of patients with colorectal liver metastases

Abstract

The role of FDG-PET in the selection of patients with colorectal liver metastases

Abstract

The role of FDG-pet in the selection of patients with colorectal liver metastases

Abstract

The role of fdg-pet in the selection of patients with colorectal liver metastases

Abstract

The role of second and third line tyrosine kinase inhibitor monotherapy in EGFR wild-type (and unknown mutational status) advanced non-small-cell lung cancer patients: Findings from a retrospective analysis.

Abstract

The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study

Articolo

The surgeon and the oncologist in non-small cell lung cancer (NSCLC)

Articolo

The tyrosine kinase AXL sustains EMT and tumour-associated inflammation in triple-negative breast cancers

Abstract

The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi

Articolo

Thiocoraline, a novel DNA polymerase inhibitor with a higher cytotoxic potency against cancer cells with mutated or inactivated p53

Articolo

Three-day low-dose Cisplatin administration in advanced non-small cell lung cancer (NSCLC): Efficacy and reduced toxicity

Abstract

Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study

Articolo

Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease.

Articolo

Timing of response evaluation with 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant pleural mesothelioma (MPM): "Early'' versus "late'' assessment

Abstract

Tivantinib in combination with Carboplatin and Pemetrexed as first line treatment in patients with advanced non-squamous NSCLC or Malignant Pleural Mesothelioma: results of phase I trial

Abstract

Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series

Articolo

Trabectedin in ovarian cancer: could we expect more?

Articolo

Trabectedin–olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma Group

Articolo

Transarterial (chemo)embolization and radiofrequency ablation for patients with hepatic metastases (mts) of head and neck carcinoma (HNC) resistant to systemic treatment

Articolo

Trastuzumab beyond progression: a challenge to translational oncology?

Articolo

Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis

Articolo

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study

Articolo

Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer

Abstract

Understanding the biology of triple-negative breast cancer

Articolo

Unlocking methodological insights on oncology efficacy endpoints: from statistical to clinical and vice versa. Letter to the editor regarding ‘Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3’ by M. P. Goetz et al

Articolo

Upfront high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (PBSCT) for international germ-cell cancer collaborative group (IGCCCG): Poor prognosis germ cell tumor (GCT) patients

Articolo

Usefulness of 1p/19q determination and correlation with outcome in newly diagnosed high-grade gliomas not including glioblastoma multiforme (HGGnotGBM)

Abstract

VINORELBINE (V) IN PEMETREXED-PRETREATED PATIENTS (PTS) WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM)

Abstract

VINORELBINE - AN ACTIVE-DRUG FOR THE MANAGEMENT OF PATIENTS WITH HEAVILY PRETREATED HODGKINS-DISEASE

Articolo

Very low risk of early relapse in patients with T1N0M0 breast cancer (BC) after surgery and adjuvant treatments in a single-institution experience

Articolo

Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas

Articolo

Vinorelbine as second or third-line therapy in pemetrexed-pretreated malignant pleural mesothelioma (MPM) patients

Abstract

WALT TRIAL (PHASE III): WEEKLY NON PEGYLATED LIPOSOMAL ANTHRACYCLINE AND TAXANE COMBINATION IN FIRSTLINE BREAST CANCER CHEMOTHERAPY

Contributo in Atti di convegno

WEEKLY BOLUS TOPOTECAN IN ADVANCED OR RECURRENT GYNAECOLOGICAL CANCERS

Articolo

WHOLE-BODY DIFFUSION MRI AND SKELETAL LESIONS IN THYROID CANCER: DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS

Articolo

Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer

Abstract

Zoledronic acid (ZA) and treatment of bone metastasis in patients with advanced lung cancer (NSCLC and SCLC).

Abstract

[18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia

Abstract

p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.

Articolo

No Results Found